Next Article in Journal
Association of Maternal Diet with Infant Birthweight in Women with Gestational Diabetes Mellitus
Previous Article in Journal
The Gestational Pathologies Effect on the Human Milk Redox Homeostasis: A First Step towards Its Definition
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Effects of Flavonoid Supplementation on Athletic Performance in Healthy Adults: A Systematic Review and Meta-Analysis

Department of Sport Science, Jeonbuk National University, Jeonju 54896, Republic of Korea
*
Author to whom correspondence should be addressed.
Nutrients 2023, 15(21), 4547; https://doi.org/10.3390/nu15214547
Submission received: 20 September 2023 / Revised: 23 October 2023 / Accepted: 24 October 2023 / Published: 26 October 2023
(This article belongs to the Section Sports Nutrition)

Abstract

:
Flavonoids, known for their antioxidant properties, can prevent reactive oxygen species (ROS) and influence athletic performance through various physiological and metabolic mechanisms. However, there are conflicting results after summarizing and analyzing the relevant literature. Hence, it is warranted to evaluate the overall impact of flavonoids on athletic performance in healthy adults based on a comprehensive and systematic review and meta-analysis. After searching four databases for literature published since their respective establishments until February 2023 and conducting publication bias and quality assessments, a total of 22 studies were ultimately included. The names and doses of flavonoids, various outcome measurements, as well as types of training, were extracted from included studies. The athletic performance outcomes from the included studies were categorized into ’performance tests’ and ’exercise tolerance,’ depending on the type of training undertaken. Several statistical results, such as pooled effect size (ES), among others, were implemented by meta-analysis using the random effects model. The results of meta-analysis suggest that there is currently sufficient evidence (ES = −0.28; 95% confidence interval (CI): [−0.50, −0.07]; p = 0.01 and ES = 0.23; 95% CI: [0.07, 0.39]; p = 0.005) to support the notion that flavonoid supplementation enhanced athletic performance in performance tests and exercise tolerance. In addition, among the subgroups, nonsignificant results were observed for athletes (p = 0.28) and acute supplementation (p = 0.41) in performance tests, as well as athletes (p = 0.57) and acute supplementation (p = 0.44) in exercise tolerance. Meanwhile, significant results were found for non-athletes (p = 0.04) and long-term supplementation (p = 0.02) in performance tests, as well as non-athletes (p = 0.005) in performance tests and long-term supplementation (p = 0.006) in exercise tolerance. The nonsignificant results were likely due to the limitation in the number of related papers, sample sizes, optimal dosage, duration, type of flavonoids, and other factors. Therefore, future research should focus on further investigating these relationships with larger sample sizes, optimal dosage, duration, and type of flavonoids to provide more robust conclusions.

1. Introduction

Flavonoids are an important class of natural products extracted from plants, which belong to plant secondary metabolites with polyphenol structure [1]. They have been found in large quantities in vegetables, cocoa, wine, and other plant-based foods as well as beverages; therefore, they are also known as dietary flavonoids [2,3]. The intake of dietary flavonoids has a favorable effect on the prevention and treatment of several diseases due to the antioxidant abilities of flavonoids [4,5,6,7,8,9]. These grounds suggest that flavonoid supplementation could potentially have a positive impact on athletic performance. Certain attributes of flavonoids, like their antioxidant properties, contribute to safeguarding against oxidative stress linked with physical activities and exercise [7]. Therefore, extensive intervention studies have been carried out to investigate whether flavonoid supplementation produces a positive effect on athletic performance. However, to date, related trials of exercise training with flavonoid supplementation have produced equivocal findings.
The beneficial impacts of flavonoids on athletic performance have been affirmed by a substantial amount of research [10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25]. Cook et al. [19] studied 14 well-trained cyclists who were supplemented with New Zealand black currant (NZBC) extract (105 mg·day−1 anthocyanins) for 7 days and improved their performance in a 16.1 km TT by 2.4%. The core reason might be that vasodilation induced by anthocyanin was able to increase the peripheral blood flow in humans to affect the athlete performance. Moreover, the findings discovered by Davis et al. [20] revealed that the intake of quercetin for 7 days increased cycling time when quercetin had induced mitochondrial biogenesis. Additionally, flavonoid supplementation (such as hesperidin [15], blueberry [18], green tea extract [17,21], montmorency cherry [22,23], grape juice [24], pomegranate extract [25], etc.) promoted athlete performance due to its protective role against muscle damage and oxidative stress caused by exercise.
In contrast, in a separate study by García-Merino et al. [26], participants engaged in a 1 km running TT after undergoing 5 g·day−1 cocoa supplementation with 425 g flavanols for 10 weeks. Surprisingly, the study did not reveal any performance improvements linked to cocoa supplementation. In addition, Askari et al.’s [27] findings indicated that the intake of quercetin and vitamin C for 8 weeks was not able to achieve the desired mitochondrial changes or demonstrate the biological effects of quercetin in the human body. These studies did not provide support for the enhancement of athletic performance through flavonoid supplementation. It was notable that several other research studies, such as Abbey et al. [28], Brandenburg et al. [29], Dean et al. [30], and Decroix et al. [31], claimed there were insignificant differences on flavonoid supplementation for athletic performance as well.
Hence, it is necessary to review the literature related to flavonoid supplementation in exercise trials to evaluate their overall impacts on athletic performance and to inspire the development of relevant studies. However, to the best of our knowledge, there has been only one paper [32] that conducted a relevant survey on exercise training combined with flavonoids. This systematic review by Ruiz-Iglesias et al. reported that flavonoid supplementation found promising results. Still, no definitive conclusions could be drawn on whether enhancing athletic performance, and the study focused on changes in immune system and inflammatory biomarkers. In summary, we aim to systematically review the effects of flavonoid supplementation on athletic performance. Athletic performance is categorized into performance tests and exercise tolerance. Performance tests include time-trial (TT) [33], while exercise tolerance encompasses time-to-exhaustion tests (TTE) [34] and graded exercise tests (GXT) [35]. Unlike Ruiz-Iglesias et al. [32], this article carries out an overall evaluation using systematic review and meta-analysis. We also investigate the impacts of flavonoid supplementation on training subjects and supplementation duration.

2. Methods

The systematic review and meta-analysis were conducted based on the Cochrane Handbook to assess the impacts of flavonoid supplementation. Concretely, this procedure was comprised of three phases. Firstly, we formulated the literature search strategies following the PRISMA® [36] and the PICOS model (see Table 1) [37]. We also established inclusion criteria, after which we preliminarily obtained some literature. Secondly, the publication bias and quality assessment of the included literature were carried out to exclude inconsistent literature. Finally, we undertook data extraction and statistical analysis. Moreover, this meta-analysis has been registered in PROSPERO (Registration number: CRD42023425112) before starting this work.

2.1. Literature Search Strategies

The two authors (Y.W. and Z.T.) conducted literature searches on PubMed, Web of Science (WOS), Cochrane Library, and Embase. All full-text literature published in English since the establishment of each database until February 2023 were reviewed. The used Boolean searching equation included: “Flavonoids” [Title/Abstract] OR “Flavonoid” [Title/Abstract] OR “Bioflavonoids” AND “Athletic Performance” [Mesh] OR “Performance, Athletic” [Title/Abstract] OR “Sports Performance” [Title/Abstract] AND “randomized” [tiab] OR “placebo” [tiab] OR “randomly” [tiab] OR “trial” [tiab] OR “groups” [tiab] OR “randomized controlled trial” [pt] OR “controlled clinical trial” [pt]. Meanwhile, a comprehensive manual search of relevant publications, including journal articles and reference lists, was performed to fully ensure the most comprehensive inclusion of pertinent studies.

2.2. Inclusion Criteria

The inclusion criteria of studies were as follows:
  • Studies were carried out on healthy adults without disease;
  • Studies for which the experiments must contain randomized controlled trial;
  • Studies for which the full text must be English.

2.3. Searching Procedure

The selection procedure of included literature was shown in Figure 1. The main procedures were as follows:
  • 148 records were obtained from specified four databases;
  • After removing 66 duplicate records, 82 articles remained, from which we removed eight reviews and 13 non-human experimental studies again;
  • A total of 61 articles met the eligibility criteria, and their full texts were assessed;
  • After finishing a comprehensive and systematic evaluation, 38 articles were excluded, seven for which full texts were not found, 10 on unrelated subjects, 12 included another supplements, seven had unsuitable outcomes, two used abnormal healthy populations and one had insufficient data, respectively;
  • Finally, a total of 22 studies were included for the meta-analysis.
Figure 1. The flow diagram of searching strategy.
Figure 1. The flow diagram of searching strategy.
Nutrients 15 04547 g001

2.4. Publication Bias

Excluding literature with negative results might lead to a biased outcome in the meta-analysis; thus, we assessed publication bias for all included literature. The funnel plots for visual interpretation and Egger’s statistics were conducted to confirm the presence of publication bias.

2.5. Quality Assessment of the Experiments

The quality and interpretation of the research were determined by two independent reviewers (Y.W. and Z.T.) in accordance with the Cochrane Collaboration Guidelines [37,38] using Review Manager 5.3 software. The checklist areas covered seven criteria of quality assessment.

2.6. Data Extraction

All relevant trial data were obtained in electronic databases and screened independently by two authors (Y.W. and Z.T.). If there was a disagreement, it was necessary to discuss or have a third-party arbitration (Z.Y.L.). From the included studies, we extracted key details such as the first author, year of publication, study type, subjects’ gender, flavonoid name and dose, administration method and timing, control group regimen, training type, and outcome measures, including sample size and mean ± standard deviation (SD). If some included studies contained more than one supplement intervention or multiple athletic output indicators, they needed to be coded as separate results according to multi-intervention and multi-output studies.

2.7. Statistical Analysis

The sample size and mean ± SD extracted from included literature were employed to conduct the meta-analysis. If the outcome measures included standard error (SE) in the extracted data, SD was calculated as SD = SE × n [39], where n was the sample size.
The standardized mean difference (SMD) involved the use of mean ± SD from experimental and control groups to standardize the difference in means, while the Effect Size (ES) was typically the weighted average of the SMD. Both were statistical measures used to quantify the magnitude of the difference between experimental and control groups. In our study, the SMD was calculated using Hedges’ g and it was used as an estimate for the effect size. Therefore, in this context, SMD and ES were equivalent [40,41,42]. The evaluation criteria of ES followed Cohen criteria: <0.2, trivial; 0.2–0.5, small; 0.5–0.8, moderate; and >0.8, large [43]. It was notable that a negative ES for a performance variable suggested an ergogenic effect. The statistics I2 indicated the degree of heterogeneity between studies [37]: 25–50%, small inconsistency; 50–75%, moderate inconsistency; and >75%, high inconsistency [43].
We used the forest plot to present the overall analysis results. If the p ≤ 0.05, 95% CI without 0, then it was statistically significant.

3. Results

3.1. Publication Bias

As shown in Figure 2, a standard funnel plot was made to assess publication bias. We found that the literature on exercise tolerance showed overall good symmetry, while the literature on performance tests exhibited some degree of asymmetry. Additionally, one study, Nieman et al. [44], surpassed the boundary of funnel plot. So, to further validate the potential presence of publication bias, an assessment was conducted using Egger’s statistical test. As a result, we found no publication bias for performance tests and exercise tolerance with an observed significance level p > 0.05 [45]. It is worth noting that the article by Nieman et al. did not have a bias risk and should be included in our analysis [44]. To sum up, publication bias was not presented in our included literature, all the papers could be used to conduct the meta-analysis.

3.2. Quality Assessment of the Experiments

The quality assessment of the experiments was conducted based on the “Cochrane Collaboration Guidelines for Assessing Quality in Experiments” [37,38]. This evaluation encompassed seven vital criteria: ensuring participants’ random assignment (Random Sequence Generation); maintaining the concealment of trial group allocation (Allocation Concealment); making certain both participants and personnel are unaware of group assignments (Blinding of Participants and Personnel); verifying that those assessing outcomes are blinded to group designations (Blinding of Outcome Assessment); addressing any potential gaps in trial data (Incomplete Outcome Data); ensuring all study results, whether favorable or not, are reported (Selective Reporting); and considering any other possible biases (Other Bias). The results are shown in Figure 3, where each item was expressed as a percentage relative to the total number of studies included. We found that there was an unclear risk of bias on random sequence generation due to 16 papers out of 22 being ambiguous about their random assignment methods. In addition, the remaining six factors of quality assessment were identified as low risk. Meanwhile, Figure 4 presented the risk of bias for each study as well. Hence, we believed the quality assessment of the experiments of all included studies presented a low risk. Therefore, we were able to proceed with a meta-analysis.

3.3. Study Characteristics

Based on the methodology of Section 2, the participants and intervention characteristics of 22 studies are shown in Table 2, which illustrates subject, experimental design, intervention, exercise protocol, outcomes, trial results (means ± SD), and main conclusion of each study. We noted from Table 2 that the effects of flavonoid supplementation on athletic performance varied across different studies, indicating a lack of consensus. Given this variability and the challenges in visually discerning any consistent impact, a thorough and systematic meta-analysis becomes imperative, especially for performance tests and exercise tolerance.

3.4. Performing a Meta-Analysis on Performance Tests

The 11 studies [5,29,30,31,44,47,48,49,53,55,56] related to TT were included in the meta-analysis of performance tests; these 11 studies contain 401 participants and 12 ESs in total. Figure 5 indicated that flavonoid supplementation presented a significant effect on the performance tests derived from the TT regimen.
Although a significant effect had been observed in healthy adults based on the above discussion, we still would like to investigate the effects of flavonoids on both athletes and non-athletes, as well as examine the impact of acute supplementation and long-term supplementation duration. In this study, the distinction between athletes and non-athletes is determined by whether they have undergone systematic professional training. Additionally, the categorization between acute supplementation and long-term supplementation is made based on the duration of flavonoid supplementation. Specifically, if the supplementation lasts for more than 7 days, it is viewed as long-term supplementation, while anything less is regarded as acute supplementation [59].
For the subgroup analysis of athletes and non-athletes, Figure 6A suggested that flavonoid supplementation revealed no effect on performance tests in athletes. Conversely, as shown in Figure 6B, flavonoid supplementation presented a significant effect on the performance tests in non-athletes.
For the subgroup analysis of acute supplementation and long-term supplementation. Figure 7A suggested that flavonoid supplementation revealed no effect on performance tests in acute supplementation. However, as shown in Figure 7B, flavonoid supplementation presented a significant effect on the performance tests when long-term supplementation duration was conducted.

3.5. Performing a Meta-Analysis on Exercise Tolerance

The 12 studies [11,20,27,28,46,47,50,51,52,54,57,58] related to TTE and GXT were used to perform the meta-analysis of exercise tolerance; these 12 studies contain 595 participants and 17 ESs in total. Figure 8 indicated that flavonoid supplementation presented a significant effect on the exercise tolerance derived from TT regimen.
Although a significant effect had been observed in healthy adults based on the above discussion, we still would like to investigate the effects of flavonoids on both athletes and non-athletes, as well as examine the impact of acute supplementation and long-term supplementation duration.
For the subgroup analysis of athletes and non-athletes, Figure 9A suggested that flavonoid supplementation revealed no effect on exercise tolerance in athletes. Conversely, as shown in Figure 9B, flavonoid supplementation presented a significant effect on exercise tolerance in non-athletes.
For the subgroup analysis of acute supplementation and long-term supplementation, Figure 10A suggested that flavonoid supplementation revealed no effect on exercise tolerance in acute supplementation. However, as shown in Figure 10B, flavonoid supplementation presented a significant effect on exercise tolerance, when long-term supplementation duration was conducted.

4. Discussion

A significant difference in performance tests had been identified when the subject had a specified dosage of flavonoid supplementation in TT regimen by meta-analysis. Based on the findings of the meta-analysis of performance tests, we firmly believed that flavonoid supplementation might contribute to slight variations in athletic performance by inducing distinct metabolic pathways or a regulation of mitochondrial biogenesis, which could result in significant differences in performance tests. Accordingly, our statements also align with the reasons for which flavonoid supplementation has produced a significant effect on performance tests in this literature [44,49,55]. However, no significant changes in performance tests were observed in certain studies, as evidenced by references [26,29,30,31,47,56]; however, we must emphasize that there might be explainable reasons behind their conclusions. The excessive intensity of exercise and the dosage of the supplement could inhibit mitochondrial biogenesis and function while suppressing excessive oxidative stress. Therefore, flavonoid supplementation can improve performance tests, but the intensity of exercise and dosage, type, as well as duration of the supplement must be appropriate [32]. Too little dosage might present non-\significance, while too much could produce a negative effect. Specific dosages might be a better choice. In addition, different flavonoids have unique impacts as well. Meanwhile, different intake duration could induce different performance changes; for example, quercetin (1000 mg/day, 2 weeks) [44], anthocyanin (150 mg/day, 6 day) [48], vitamins and quercetin (600 mg/day, 6 weeks) [49] citrus flavonoid (500 mg/day, 4 weeks) [53], and soy (30 g, once) [55] improved performance.
Results from the athlete and non-athlete subgroup analysis suggested that the exercise subjects’ characteristics might influence the efficacy of flavonoid supplementation in performance tests. We observed significant results in non-athletes but not in athletes, which might be attributed to exercise subjects’ characteristics. García-Merino et al. [26] reported a statistically insignificant improvement increased by 1.27% after athlete intake flavonoid supplementation in a TT experiment. However, Overdevest et al. [53] found a statistically significant improvement increased by 5% after non-athletes underwent 500 mg·day−1 hesperidin supplementation for 4 weeks. It is noteworthy that non-athletes have greater room for improvement compared to athletes. The reason revealed is also consistent with the conclusion discussed by Hopkins et al. in [60]. Therefore, the exercise subjects’ characteristics should be emphasized.
There was a significant improvement for performance tests with long-term supplementation, but for acute supplementation, it was insignificant. These could be related to the duration of supplementation, because the long-term could result in an increase in muscle-oxidation [61,62]. Decroix et al. [31] found that acute supplementation of cocoa flavanols (CF) could marginally enhance the relative power output following TT exercise, and Dean et al. [30] carried out acute supplementation with 270 mg of green tea extract. This acute supplementation did not produce improvements. However, Wolfram et al. [63] observed that undergoing green tea supplementation beyond 12 weeks might yield more beneficial effects in human experiments.
A significant difference of exercise tolerance has been identified when the subject intake specified dosage flavonoid supplementation in TTE or GXT regimen by meta-analysis. As we all know, flavonoids boost exercise tolerance by amplifying oxygen delivery to muscles, increasing nitric oxide (NO) concentrations and strengthening antioxidant defenses. For example, Van Iersel et al. [57] carried out the daily intake of 400 mg/day of citrus flavonoids over 8 weeks, resulting in a substantial enhancement in the capacity to supply oxygen to muscles. This improvement was achieved through the elevation of NO levels, ultimately leading to increased average power output in the Wingate test. Furthermore, Yarahmadi, et al. [58] conducted the Bruce exercise test after 6 consecutive weeks of supplementing the subjects with 100 mg of anthocyanins per day, indicated a significant improvement in Vo2 max due to attributing to the antioxidant properties exhibited by anthocyanins. This coincides perfectly with our findings. Meanwhile, we must consider the effects of dosage, type, and duration of flavonoid supplementation as well as exercise subjects’ characteristics too. Proper dosing can extend aerobic endurance and reduce recovery time. Some benefit cardiovascular endurance, others aid muscle recovery; for example, luteolin and mangiferin (50 mg and 140 mg for 48 h) [11], luteolin and mangiferin (100 mg and 420 mg for 15 days) [11], lactaway (150 mL for once) [46], quercetin (1000 mg/day, 7 days) [20], 2S-hesperidin (500 mg for once) [50], 2S-hesperidin (500 mg/day, 8 weeks) [51], New Zealand black currant (300 mg/day, 7 days) [54], citrus flavonoid (400 mg or 500 mg/day, 4 weeks) [57], and anthocyanin (100 mg/day, 6 weeks) [58] improved performance.
The results from the athlete and non-athlete subgroup analysis indicated that the exercise subjects’ characteristics might influence the efficacy of flavonoid supplementation on exercise tolerance as well. Athletes, due to their prolonged, high-intensity training, have developed robust adaptive responses, particularly in areas of antioxidant activity, energy metabolism, and inflammatory reactions. When they supplement with flavonoids, these compounds may further amplify these established adaptive mechanisms. In contrast, non-athletes might not have such pronounced adaptive responses. This difference in adaptive reactions explains why athletes and non-athletes may exhibit distinct endurance performance outcomes after flavonoid supplementation. Well-trained athletes showcase enhanced physiological adaptations due to consistent training, particularly in areas like antioxidant activity, mitochondrial function, and NO production [20,64]. While athletes already exhibit superior antioxidative and mitochondrial capacities, non-athletes can achieve more pronounced performance boosts from quercetin supplementation [54]. Furthermore, black currant intake in healthy adults can delay muscle fatigue and combat exercise-induced ROS. Such benefits are largely attributed to the role of exercise in activating eNOS, promoting NO synthesis, and enhancing blood flow [65]. Therefore, supplementation with flavonoids has been proven effective for non-athletes, but its impact on athletes still warrants further research. Moreover, adaptability and the characteristics of the subjects should be taken into account.
In addition, regarding acute supplementation and long-term supplementation in exercise tolerance. Long-term supplementation with flavonoids may enhance endurance by improving blood flow, strengthening antioxidant defenses, alleviating chronic inflammation, and optimizing energy metabolism. In contrast, acute supplementation might offer immediate vasodilation, short-term antioxidant protection, and rapid alleviation of inflammatory responses. As noted by Van Iersel et al. [57], the citrus flavonoid group could enhance athletes’ anaerobic capacity after 8 weeks by upregulating NO, scavenging ROS, or regulating mitochondrial biogenesis. Gelabert-Rebato et al. [11] declared that peak power output exhibited a significant increase whether it is a long-term supplementation or an acute supplementation after oral mangiferin and luteolin supplementation. There were only three studies of acute flavonoid supplementation, which could result in the increasing risk of inaccurate estimates. Therefore, it is imperative to exercise prudence in interpreting the findings, while taking into account the constraints posed by the limited scope and number of studies included in the analysis.
Finally, in view of the limitations of exercise regimens, sample size, flavonoid intake, diverse designs and target population led to unstable statistical results, so, further research was necessary to establish much more incontrovertible evidence regarding exercise regimens. While many of the articles included in the analysis focused on evaluating athletic performance, a subset of studies only reported it as a secondary outcome. As a result, a comprehensive and thorough evaluation of athletic performance cannot be conducted. In terms of sample size, in clinical studies, experimental subjects were often limited by various factors such as specific populations, time constraints, and resource availability, leading to insufficient sample sizes and hindering more in-depth analyses. Concerning the number of relevant studies, the fewer related research studies result in an unstable statistical result; for example, there were only three studies for acute flavonoid supplementation on acute supplementation subgroup of exercise tolerance, but at least two studies were required to perform a meta-analysis [35]. Fewer studies might increase the risk of inaccurate estimates and limit the generalizability of the results. Thereby, the exercise regimens, sample size, and the number of correlated research were challenges in conducting systematic review and meta-analysis, these challenges provided opportunities for our future research endeavors and underscore the necessity for further investigations in this field. Future studies on flavonoid supplementation and athletic performance should consider diverse designs, notably randomized controlled trials and dose-response trials, while targeting varied populations, including elite vs. recreational athletes, different age groups, and sport-specific groups. It is essential to control for confounding factors such as diet, training load, and other supplements to ensure accurate findings.
In summary, flavonoid supplementation had a significant improvement in performance tests using the TT regimen. Meanwhile, the subgroup analysis, athletes and non-athletes as well as for acute supplementation and long-term supplementation, was carried out, and found that supplementing flavonoid is slightly beneficial for non-athlete and long-term supplementation, whereas it was not useful for athlete and acute supplementation. However, it was essential to conduct further research to solve some limitations. Additionally, flavonoid supplementation demonstrated that there was a modest yet statistically significant ES for exercise tolerance using the TTE and GXT regimens as well. Subsequently, we performed further subgroup analyses on exercise tolerance too. Results indicated that the non-athletes group presented a significant improvement, but there was no significance in athletes group. Meanwhile, long-term supplementation was found to effectively enhance exercise tolerance, whereas no changes were observed with acute supplementation. Consequently, athletic performance would present a significant improvement in exercise tolerance when non-athletes took flavonoid supplementation for a long-term. However, much further research with a larger sample size was essential for athletes and acute supplementation.

5. Conclusions

In summary, our meta-analysis results indicate that flavonoid compounds can provide positive support for the athletic performance of adults. Particularly in the cases of non-athletes and/or long-term supplementation, flavonoid supplementation is effective in enhancing athletic performance. However, factors such as different training environments, variations in supplement dosage, and duration of intake can influence its effects. Thus, further research is needed to establish more concrete evidence regarding the impact of flavonoid supplementation on athletic performance.

Author Contributions

The authors’ responsibilities were as follows—Y.W.: initiated the idea of this review and designed it; Y.W. and Z.T.: collected the data, performed the meta-analysis; Y.W.: wrote the manuscript; Z.T. and Z.L: selected the data and assessed the articles; J.C.K.: critically reviewed the article for important intellectual content; Y.W., Z.T., Z.L. and J.C.K.: assessed the articles and helped to draft and critically review the article for important intellectual content; and all authors: read and approved the final manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in the inserted articles.

Acknowledgments

We thank Xia Wu for her advice on data analysis and English support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Singh, B.; Kumar, A.; Malik, A.K. Flavonoids biosynthesis in plants and its further analysis by capillary electrophoresis. Electrophoresis 2017, 38, 820–832. [Google Scholar] [CrossRef] [PubMed]
  2. Steinberg, F.M.; Bearden, M.M.; Keen, C.L. Cocoa and chocolate flavonoids: Implications for cardiovascular health. J. Am. Diet. Assoc. 2003, 103, 215–223. [Google Scholar] [CrossRef] [PubMed]
  3. Baby, J.; Devan, A.R.; Kumar, A.R.; Gorantla, J.N.; Nair, B.; Aishwarya, T.S.; Nath, L.R. Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review. J. Food Biochem. 2021, 45, e13761. [Google Scholar] [CrossRef] [PubMed]
  4. Rupasinghe, H.V. Special Issue “Flavonoids and Their Disease Prevention and Treatment Potential”: Recent Advances and Future Perspectives. Molecules 2020, 25, 4746. [Google Scholar] [CrossRef] [PubMed]
  5. García-Barrado, M.J.; Iglesias-Osma, M.C.; Pérez-García, E.; Carrero, S.; Blanco, E.J.; Carretero-Hernández, M.; Carretero, J. Role of flavonoids in the interactions among obesity, inflammation, and autophagy. Pharmaceuticals 2020, 13, 342. [Google Scholar] [CrossRef] [PubMed]
  6. Liskova, A.; Koklesova, L.; Samec, M.; Varghese, E.; Abotaleb, M.; Samuel, S.M.; Smejkal, K.; Biringer, K.; Petras, M.; Blahutova, D.; et al. Implications of flavonoids as potential modulators of cancer neovascularity. J. Cancer Res. Clin. Oncol. 2020, 146, 3079–3096. [Google Scholar] [CrossRef] [PubMed]
  7. Chen, Q.; Xu, B.; Huang, W.; Amrouche, A.T.; Maurizio, B.; Simal-Gandara, J.; Tundis, R.; Xiao, J.; Zou, L.; Lu, B. Edible flowers as functional raw materials: A review on anti-aging properties. Trends Food Sci. Technol. 2020, 106, 30–47. [Google Scholar] [CrossRef]
  8. Li, G.; Ding, K.; Qiao, Y.; Zhang, L.; Zheng, L.; Pan, T.; Zhang, L. Flavonoids Regulate Inflammation and Oxidative Stress in Cancer. Molecules 2020, 25, 5628. [Google Scholar] [CrossRef]
  9. Cichon, N.; Saluk-Bijak, J.; Gorniak, L.; Przyslo, L.; Bijak, M. Flavonoids as a Natural Enhancer of Neuroplasticity—An Overview of the Mechanism of Neurorestorative Action. Antioxidants 2020, 9, 1035. [Google Scholar] [CrossRef]
  10. Kressler, J.; Millard-Stafford, M.; Warren, G.L. Quercetin and endurance exercise capacity: A systematic review and meta-analysis. Med. Sci. Sports Exerc. 2011, 43, 2396–2404. [Google Scholar] [CrossRef]
  11. Gelabert-Rebato, M.; Wiebe, J.C.; Martin-Rincon, M.; Galvan-Alvarez, V.; Curtelin, D.; Perez-Valera, M.; Juan Habib, J.; Pérez-López, A.; Vega, T.; Morales-Alamo, D.; et al. Enhancement of exercise performance by 48 hours, and 15-day supplementation with magiferin and luteolin in men. Nutrients 2019, 11, 344. [Google Scholar] [CrossRef] [PubMed]
  12. Braakhuis, A.J.; Somerville, V.X.; Hurst, R.D. The effect of New Zealand blackcurrant on sport performance and related biomarkers: A systematic review and meta-analysis. J. Int. Soc. Sports Nutr. 2020, 17, 25. [Google Scholar] [CrossRef] [PubMed]
  13. Davis, J.M.; Murphy, E.A.; Carmichael, M.D. Effects of the Dietary Flavonoid Quercetin Upon Performance and Health. Optom. Vis. Sci. 2009, 8, 206–213. [Google Scholar] [CrossRef] [PubMed]
  14. Braakhuis, A.J.; Hopkins, W.G. Impact of Dietary Antioxidants on Sport Performance: A Review. Sports Med. 2015, 45, 939–955. [Google Scholar] [CrossRef] [PubMed]
  15. Imperatrice, M.; Cuijpers, I.; Troost, F.J.; Sthijns, M.M. Hesperidin functions as an ergogenic aid by increasing endothelial function and decreasing exerciseinduced oxidative stress and inflammation, thereby contributing to improved exercise performance. Nutrients 2022, 14, 2955. [Google Scholar] [CrossRef] [PubMed]
  16. Decroix, L.; Soares, D.D.; Meeusen, R.; Heyman, E.; Tonoli, C. Cocoa Flavanol Supplementation and Exercise: A Systematic Review. Sports Med. 2018, 48, 867–892. [Google Scholar] [CrossRef] [PubMed]
  17. Jówko, E.; Sacharuk, J.; Balasińska, B.; Ostaszewski, P.; Charmas, M.; Charmas, R. Green tea extract supplementation gives protection against exercise-induced oxidative damage in healthy men. Nutr. Res. 2011, 31, 813–821. [Google Scholar] [CrossRef] [PubMed]
  18. Bloedon, T.; Vendrame, S.; Bolton, J.; Lehnhard, R.; Riso, P.; Klimis-Zacas, D. The effect of wild blueberry (Vaccinium angustifolium) consumption on oxidative stress, inflammation, and DNA damage associated with exercise. Comp. Exerc. Physiol. 2015, 11, 173–181. [Google Scholar] [CrossRef]
  19. Cook, M.D.; Myers, S.D.; Blacker, S.D.; Willems, M.E.T. New Zealand blackcurrant extract improves cycling performance and fat oxidation in cyclists. Eur. J. Appl. Physiol. 2015, 115, 2357–2365. [Google Scholar] [CrossRef]
  20. Davis, J.M.; Carlstedt, C.J.; Chen, S.; Carmichael, M.D.; Murphy, E.A. The Dietary Flavonoid Quercetin Increases VO2max and Endurance Capacity. Int. J. Sport Nutr. Exerc. Metab. 2010, 20, 56–62. [Google Scholar] [CrossRef]
  21. Kuo, Y.-C.; Lin, J.-C.; Bernard, J.R.; Liao, Y.-H. Green tea extract supplementation does not hamper endurance-training adaptation but improves antioxidant capacity in sedentary men. Appl. Physiol. Nutr. Metab. 2015, 40, 990–996. [Google Scholar] [CrossRef] [PubMed]
  22. Levers, K.; Dalton, R.; Galvan, E.; O’connor, A.; Goodenough, C.; Simbo, S.; Mertens-Talcott, S.U.; Rasmussen, C.; Greenwood, M.; Riechman, S.; et al. Effects of powdered Montmorency tart cherry supplementation on acute endurance exercise performance in aerobically trained individuals. J. Int. Soc. Sports Nutr. 2016, 13, 22. [Google Scholar] [CrossRef] [PubMed]
  23. Morgan, P.T.; Barton, M.J.; Bowtell, J.L. Montmorency cherry supplementation improves 15-km cycling time-trial performance. Eur. J. Appl. Physiol. 2019, 119, 675–684. [Google Scholar] [CrossRef] [PubMed]
  24. Toscano, L.T.; Tavares, R.L.; Toscano, L.T.; da Silva, C.S.O.; de Almeida, A.E.M.; Biasoto, A.C.T.; Gonçalves, M.d.C.R.; Silva, A.S. Potential ergogenic activity of grape juice in runners. Appl. Physiol. Nutr. Metab. 2015, 40, 899–906. [Google Scholar] [CrossRef] [PubMed]
  25. Torregrosa-García, A.; Ávila-Gandía, V.; Luque-Rubia, A.J.; Abellán-Ruiz, M.S.; Querol-Calderón, M.; López-Román, F.J. Pomegranate Extract Improves Maximal Performance of Trained Cyclists after an Exhausting Endurance Trial: A Randomised Controlled Trial. Nutrients 2019, 11, 721. [Google Scholar] [CrossRef] [PubMed]
  26. García-Merino, J.Á.; Moreno-Pérez, D.; de Lucas, B.; Montalvo-Lominchar, M.G.; Muñoz, E.; Sánchez, L.; Naclerio, F.; Herrera-Rocha, K.M.; Moreno-Jiménez, M.R.; Rocha-Guzmán, N.E.; et al. Chronic flavanol-rich cocoa powder supplementation reduces body fat mass in endurance athletes by modifying the follistatin/myostatin ratio and leptin levels. Food Funct. 2020, 11, 3441–3450. [Google Scholar] [CrossRef] [PubMed]
  27. Askari, G.; Ghiasvand, R.; Paknahad, Z.; Karimian, J.; Rabiee, K.; Sharifirad, G.; Feizi, A. The effects of quercetin supplementation on body composition, exercise performance and muscle damage indices in athletes. Int. J. Prev. Med. 2013, 4, 21. [Google Scholar]
  28. Abbey, E.L.; Rankin, J.W. Effect of quercetin supplementation on repeated-sprint performance, xanthine oxidase activity, and inflammation. Int. J. Sport Nutr. Exerc. Metab. 2011, 21, 91–96. [Google Scholar] [CrossRef]
  29. Brandenburg, J.P.; Giles, L.V. Blueberry supplementation reduces the blood lactate response to running in normobaric hypoxia but has no effect on performance in recreational runners. J. Int. Soc. Sports Nutr. 2021, 18, 26. [Google Scholar] [CrossRef]
  30. Dean, S.; Braakhuis, A.; Paton, C. The Effects of EGCG on Fat Oxidation and Endurance Performance in Male Cyclists. Int. J. Sport Nutr. Exerc. Metab. 2009, 19, 624–644. [Google Scholar] [CrossRef]
  31. Decroix, L.; Tonoli, C.; Soares, D.D.; Descat, A.; Drittij-Reijnders, M.-J.; Weseler, A.R.; Bast, A.; Stahl, W.; Heyman, E.; Meeusen, R. Acute cocoa Flavanols intake has minimal effects on exercise-induced oxidative stress and nitric oxide production in healthy cyclists: A randomized controlled trial. J. Int. Soc. Sports Nutr. 2017, 14, 28. [Google Scholar] [CrossRef] [PubMed]
  32. Ruiz-Iglesias, P.; Gorgori-González, A.; Massot-Cladera, M.; Castell, M.; Pérez-Cano, F.J. Does Flavonoid Consumption Improve Exercise Performance? Is It Related to Changes in the Immune System and Inflammatory Biomarkers? A Systematic Review of Clinical Studies since 2005. Nutrients 2021, 13, 1132. [Google Scholar] [CrossRef] [PubMed]
  33. Albertus, Y.; Tucker, R.; Gibson, A.S.C.; Lambert, E.V.; Hampson, D.B.; Noakes, T.D. Effect of Distance Feedback on Pacing Strategy and Perceived Exertion during Cycling. Med. Sci. Sports Exerc. 2005, 37, 461–468. [Google Scholar] [CrossRef] [PubMed]
  34. Laursen, P.B.; Francis, G.T.; Abbiss, C.R.; Newton, M.J.; Nosaka, K. Reliability of Time-to-Exhaustion versus Time-Trial Running Tests in Runners. Med. Sci. Sports Exerc. 2007, 39, 1374–1379. [Google Scholar] [CrossRef]
  35. Van De Walle, G.P.; Vukovich, M.D. The effect of nitrate supplementation on exercise tolerance and performance: A systematic review and meta-analysis. J. Strength Cond. Res. 2018, 32, 1796–1808. [Google Scholar] [CrossRef] [PubMed]
  36. Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann. Intern. Med. 2009, 151, W65–W94. [Google Scholar] [CrossRef] [PubMed]
  37. Cumpston, M.; Li, T.; Page, M.; Chandler, J.; Welch, V.; Higgins, J.P.; Thomas, J. Updated guidance for trusted systematic reviews: A new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst. Rev. 2019, 10, ED000142. [Google Scholar] [CrossRef] [PubMed]
  38. Higgins, J.; Green, S.; Ben Van Den, A. Cochrane Handbook for Systematic Reviews of Interventions. Int. Coach. Psychol. Rev. 2020, 15, 123–125. [Google Scholar] [CrossRef]
  39. Hozo, I.; Djulbegovic, B.; Clark, O.; Lyman, G.H. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med. Res. Methodol. 2005, 5, 13. [Google Scholar] [CrossRef]
  40. LV, H. Estimation of a single-effect size: Parametric and non-parametric methods. In Statistical Methods for Meta-Analysis; Academic Press: Cambridge, MA, USA, 1985. [Google Scholar]
  41. Hedges, L.V. Distribution theory for Glass’s estimator of effect size and related estimators. J. Educ. Stat. 1981, 6, 107–128. [Google Scholar] [CrossRef]
  42. Andrade, C. Mean difference, standardized mean difference (SMD), and their use in meta-analysis: As simple as it gets. J. Clin. Psychiatry 2020, 81, 11349. [Google Scholar] [CrossRef] [PubMed]
  43. DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7, 177–188. [Google Scholar] [CrossRef] [PubMed]
  44. Nieman, D.C.; Williams, A.S.; Shanely, R.A.; Jin, F.; Mcanulty, S.R.; Triplett, N.T.; Austin, M.D.; Henson, D.A. Quercetin’s Influence on Exercise Performance and Muscle Mitochondrial Biogenesis. Med. Sci. Sports Exerc. 2010, 42, 338–345. [Google Scholar] [CrossRef] [PubMed]
  45. Egger, M.; Smith, G.D.; Schneider, M.; Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315, 629–634. [Google Scholar] [CrossRef] [PubMed]
  46. Bentley, D.J.; Dank, S.; Coupland, R.; Midgley, A.; Spence, I. Acute Antioxidant Supplementation Improves Endurance Performance in Trained Athletes. Res. Sports Med. 2012, 20, 1–12. [Google Scholar] [CrossRef] [PubMed]
  47. Bigelman, K.A.; Fan, E.H.; Chapman, D.P.; Freese, E.C.; Trilk, J.L.; Cureton, K.J. Effects of Six Weeks of Quercetin Supplementation on Physical Performance in ROTC Cadets. Mil. Med. 2010, 175, 791–798. [Google Scholar] [CrossRef] [PubMed]
  48. Howatson, G.; Snaith, G.C.; Kimble, R.; Cowper, G.; Keane, K.M. Improved endurance running performance following haskap berry (Lonicera caerulea L.) ingestion. Nutrients 2022, 14, 780. [Google Scholar] [CrossRef] [PubMed]
  49. MacRae, H.S.-H.; Mefferd, K.M. Dietary Antioxidant Supplementation Combined with Quercetin Improves Cycling Time Trial Performance. Int. J. Sport Nutr. Exerc. Metab. 2006, 16, 405–419. [Google Scholar] [CrossRef]
  50. Martínez-Noguera, F.J.; Marín-Pagán, C.; Carlos-Vivas, J.; Rubio-Arias, J.A.; Alcaraz, P.E. Acute Effects of Hesperidin in Oxidant/Antioxidant State Markers and Performance in Amateur Cyclists. Nutrients 2019, 11, 1898. [Google Scholar] [CrossRef]
  51. Martínez-Noguera, F.J.; Marín-Pagán, C.; Carlos-Vivas, J.; Alcaraz, P.E. Effects of 8 Weeks of 2S-Hesperidin Supplementation on Performance in Amateur Cyclists. Nutrients 2020, 12, 3911. [Google Scholar] [CrossRef]
  52. McCormick, R.; Peeling, P.; Binnie, M.; Dawson, B.; Sim, M. Effect of tart cherry juice on recovery and next day performance in well-trained Water Polo players. J. Int. Soc. Sports Nutr. 2016, 13, 41. [Google Scholar] [CrossRef] [PubMed]
  53. Overdevest, E.; Wouters, J.A.; Wolfs, K.H.M.; Van Leeuwen, J.J.M.; Possemiers, S. Citrus Flavonoid Supplementation Improves Exercise Performance in Trained Athletes. J. Sports Sci. Med. 2018, 17, 24–30. [Google Scholar] [PubMed]
  54. Perkins, I.C.; Vine, S.A.; Blacker, S.D.; Willems, M.E.T. New Zealand Blackcurrant Extract Improves High-Intensity Intermittent Running. Int. J. Sport Nutr. Exerc. Metab. 2015, 25, 487–493. [Google Scholar] [CrossRef] [PubMed]
  55. Seeley, A.D.; Jacobs, K.A.; Signorile, J.F. Acute soy supplementation improves 20-km time trial performance, power, and speed. Med. Sci. Sport. Exerc. 2019, 52, 170–177. [Google Scholar] [CrossRef] [PubMed]
  56. Sharp, M.A.; Hendrickson, N.R.; Staab, J.S.; McClung, H.L.; Nindl, B.C.; Michniak-Kohn, B.B. Effects of Short-Term Quercetin Supplementation on Soldier Performance. J. Strength Cond. Res. 2012, 26, S53–S60. [Google Scholar] [CrossRef] [PubMed]
  57. Van Iersel, L.E.; Stevens, Y.R.; Conchillo, J.M.; Troost, F.J. The effect of citrus flavonoid extract supplementation on anaerobic capacity in moderately trained athletes: A randomized controlled trial. J. Int. Soc. Sports Nutr. 2021, 18, 2. [Google Scholar] [CrossRef] [PubMed]
  58. Yarahmadi, M.; Askari, G.; Kargarfard, M.; Ghiasvand, R.; Hoseini, M.; Mohamadi, H.; Asadi, A. The effect of anthocyanin supplementation on body composition, exercise performance and muscle damage indices in athletes. Int. J. Prev. Med. 2014, 5, 1594. [Google Scholar] [PubMed]
  59. Fairlie-Jones, L.; Davison, K.; Fromentin, E.; Hill, A.M. The Effect of Anthocyanin-Rich Foods or Extracts on Vascular Function in Adults: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Nutrients 2017, 9, 908. [Google Scholar] [CrossRef]
  60. Hopkins, W.G.; Hawley, J.A.; Burke, L.M. Design and analysis of research on sport performance enhancement. Med. Sci. Sports Exerc. 1999, 31, 472–485. [Google Scholar] [CrossRef]
  61. Murase, T.; Haramizu, S.; Shimotoyodome, A.; Tokimitsu, I.; Hase, T. Green tea extract improves running endurance in mice by stimulating lipid utilization during exercise. Am. J. Physiol. Integr. Comp. Physiol. 2006, 290, R1550–R1556. [Google Scholar] [CrossRef]
  62. Murase, T.; Haramizu, S.; Shimotoyodome, A.; Nagasawa, A.; Tokimitsu, I. Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice. Am. J. Physiol. Integr. Comp. Physiol. 2005, 288, R708–R715. [Google Scholar] [CrossRef]
  63. Wolfram, S.; Wang, Y.; Thielecke, F. Anti-obesity effects of green tea: From bedside to bench. Mol. Nutr. Food Res. 2006, 50, 176–187. [Google Scholar] [CrossRef]
  64. Green, D.J.; Maiorana, A.; O’Driscoll, G.; Taylor, R. Effect of exercise training on endothelium-derived nitric oxide function in humans. J. Physiol. 2004, 561, 1–25. [Google Scholar] [CrossRef]
  65. Newsholme, P.; De Bittencourt, P.I.H.; Hagan, C.O.; De Vito, G.; Murphy, C.; Krause, M.S. Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: The central role of ROS and nitric oxide. Clin. Sci. 2010, 118, 341–349. [Google Scholar] [CrossRef]
Figure 2. Funnel plot: publication bias risk in performance test (A) and in exercise tolerance (B). Where both slanting dotted lines represent the expected 95% CI; vertical dotted line refer to the position of no effect; circles represent individual studies.
Figure 2. Funnel plot: publication bias risk in performance test (A) and in exercise tolerance (B). Where both slanting dotted lines represent the expected 95% CI; vertical dotted line refer to the position of no effect; circles represent individual studies.
Nutrients 15 04547 g002
Figure 3. Graph of risk of bias.
Figure 3. Graph of risk of bias.
Nutrients 15 04547 g003
Figure 4. Summary of risk of bias [11,20,26,27,28,29,30,31,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58]. Where the “green +” represents low risk of bias; “yellow ?” represents unclear risk of bias; “red -” represents high risk of bias.
Figure 4. Summary of risk of bias [11,20,26,27,28,29,30,31,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58]. Where the “green +” represents low risk of bias; “yellow ?” represents unclear risk of bias; “red -” represents high risk of bias.
Nutrients 15 04547 g004
Figure 5. Forest plot: meta-analysis of flavonoid impacts on performance tests [26,29,30,31,44,47,48,49,53,55,56]. Where each color square represents the point estimate of the ES (SMD); black diamond represents the combined or pooled effect size and its 95% CI from all the studies.
Figure 5. Forest plot: meta-analysis of flavonoid impacts on performance tests [26,29,30,31,44,47,48,49,53,55,56]. Where each color square represents the point estimate of the ES (SMD); black diamond represents the combined or pooled effect size and its 95% CI from all the studies.
Nutrients 15 04547 g005
Figure 6. Forest plot: athlete and non-athlete subgroup analysis of flavonoid impacts on performance tests. (A) Athlete subgroup. (B) Non-athlete subgroup [26,29,30,31,44,47,48,49,53,55,56].
Figure 6. Forest plot: athlete and non-athlete subgroup analysis of flavonoid impacts on performance tests. (A) Athlete subgroup. (B) Non-athlete subgroup [26,29,30,31,44,47,48,49,53,55,56].
Nutrients 15 04547 g006
Figure 7. Forest plot: acute and long-term supplementation subgroup analysis of flavonoid impacts on performance tests. (A) Acute supplementation subgroup. (B) Long-term supplementation subgroup [26,29,30,31,44,47,48,49,53,55,56].
Figure 7. Forest plot: acute and long-term supplementation subgroup analysis of flavonoid impacts on performance tests. (A) Acute supplementation subgroup. (B) Long-term supplementation subgroup [26,29,30,31,44,47,48,49,53,55,56].
Nutrients 15 04547 g007
Figure 8. Forest plot: meta-analysis of flavonoid impacts on exercise tolerance [11,20,27,28,46,47,50,51,52,54,57,58].
Figure 8. Forest plot: meta-analysis of flavonoid impacts on exercise tolerance [11,20,27,28,46,47,50,51,52,54,57,58].
Nutrients 15 04547 g008
Figure 9. Forest plot: athlete and non-athlete subgroup analysis of flavonoid impacts on exercise tolerance. (A) Athlete subgroup. (B) Non-athlete subgroup [11,20,27,28,46,47,50,51,52,54,57,58].
Figure 9. Forest plot: athlete and non-athlete subgroup analysis of flavonoid impacts on exercise tolerance. (A) Athlete subgroup. (B) Non-athlete subgroup [11,20,27,28,46,47,50,51,52,54,57,58].
Nutrients 15 04547 g009
Figure 10. Forest plot: acute and long-term supplementation subgroup analysis of flavonoid impacts on exercise tolerance. (A) Acute supplementation subgroup. (B) Long-term supplementation subgroup [11,20,27,28,46,47,50,51,52,54,57,58].
Figure 10. Forest plot: acute and long-term supplementation subgroup analysis of flavonoid impacts on exercise tolerance. (A) Acute supplementation subgroup. (B) Long-term supplementation subgroup [11,20,27,28,46,47,50,51,52,54,57,58].
Nutrients 15 04547 g010
Table 1. PICOS criteria used to perform the systematic review.
Table 1. PICOS criteria used to perform the systematic review.
PICOSStandard
Population
Intervention
Healthy adults
Flavonoid supplementation
ComparatorPlacebo
OutcomeAthletic performance
Study designRandomized controlled trial (RCT)
Table 2. Participants and intervention characteristics.
Table 2. Participants and intervention characteristics.
ReferenceSubject, nExperimental DesignInterventionExercise ProtocolOutcomesTrial Results
(Mean ± SD)
Main
Conclusion
Abbey, 2011 [28]Athletes, n = 15 (males)Double-blinded,
cross-over, RCT
1000 mg Quercetin a
day for 7 days
12 × 30-m sprintsAverage timesQ = 4.85 ± 0.24 s
P = 4.85 ± 0.24 s
Askari, 2013 [27]Students with athletic
history 3 years, n = 60
(males)
Double-blind, parallel,
RCT
500 mg Quercetin
& 250 mg Vitamin C
500 mg a day for 8 weeks
Bruce protocolTotal distanceQ = 1289.07 ± 221.74 m
P = 1233.92 ± 209.85 m
Bentley, 2012 [46]Cyclists, n = 9 (males)Double-blind, RCT150 mL Lactaway for onceTime to exhaustionTotal timeLA = 574 ± 265 s
P = 494 ± 213 s
Bigelman, 2010 [47]Moderately trained
person, n = 58 (44 males
and 14 females)
Double-blind, parallel,
RCT
1000 mg Quercetin a
day for 42–54 days
2-mile running TT,
Wingate anaerobic
test, 36.6-m Sprint
Total time
Mean power
Total time
Q = 14.92 ± 1.74 min
P = 15.17 ± 1.67 min (a)
Q = 551.72 ±110.99 W
P = 513.21 ± 104.98 W (b)
Q = 5.78 ± 0.50 s
P = 5.76 ± 0.52 s (c)
Brandenburg, 2021 [29]Recreational runners, n = 11 (4 males and 7 females)Double-blinded,
cross-over, RCT
324 g Blueberry a day
for 4 days
30 min TT in norm baric hypoxiaTotal distanceBLU = 4.47 ± 0.69 km
P = 4.46 ± 0.62 km
Davis, 2010 [20]Student volunteers, n =
12 (7 males and 5 females)
Double-blinded,
cross-over, RCT
1000 mg Quercetin a
day for 7 days
EnduranceRide timeQ = 105.7 ± 21.8 min
P = 93.4 ± 22.9 min
Dean, 2009 [30]Well-trained cyclists, n = 10 (males)Double-blinded,
cross-over, RCT
270 mg Green-tea extract
(TEAVIGO) a day for 5
days and 270 × 2 on Day 6
40-km Cycling TTTotal timeGT = 3652 ± 295 s
P = 3627 ± 211 s
Decroix, 2017 [31]Cyclists, n = 12 (male)Double-blind,
cross-over, RCT
900 mg Cocoa Flavanols
for once
Two 30 min running TTTotal timeCO = 29.22± 1.32 min
P = 29.78 ± 1.97 min (a)
CO = 30.0 ± 1.58 min
P = 29.57 ± 1.82 min (b)
García, 2020 [26]Endurance cross-country
athletes, n = 44 (males)
Blind, parallel, RCT5 g Cocoa a day for 10 weeks (425 mg of flavanols)1 km Running TTTotal timeCO = 3.15 ± 0.21 min
P = 3.19 ± 0.27 min
Gelabert, 2019 [11]Physical education
students, n = 12 (male)
Double-blind,
cross-over, RCT
L: 50 mg peanut and 140 mg MLE a day for 48 h and 15 days
H: 100 mg peanut and 420 mg MLE a day for 48 h and 15 days
Incremental exercise testOutput power48 h MA + LU (L) =
288 ± 86.6 W
P = 277 ± 103.9 W (a)
MA + LU (H) = 291 ±
166.3 W
P = 291 ± 166.3 W(b)
15 days MA + LU (L) =
271 ± 83.1 W
P = 282 ± 86.6 W(c)
MA + LU (H) = 291 ±
162.8 W
P = 286 ± 145.5 W(d)
Howatson, 2022 [48]Volunteer, n = 30 (male)Double-blind, parallel, RCTHaskap (150 mg Anthocyanin) a day for 6 days5 km Running TTTotal timeHas = 1282 ± 140 s
P = 1384 ±193 s
MacRae, 2006 [49]Elite cyclists, n = 11
(male)
Double-blind,
cross-over, RCT
600 mg Vitamins & Quercetin a day for 6 weeks30 km Cycling TTTotal timeFRS = 50.70 ± 2.22 min
P = 52.30 ± 2.03 min
Martínez, 2019 [50]Amateur cyclists, n = 16
(male)
Single-blind, cross-over,
RCT
500 mg 2S-hesperidin
for once
4 × 30 s all-out sprintsAverage power2S-hes = 567.84 ± 55.44 W
P = 555.25 ± 51.81 W
Martínez, 2020 [51]Amateur cyclists,
n = 40 (male)
Double-blind, parallel,
RCT
500 mg 2S-hesperidin a
day for 8 weeks
Wingate testAbsolute peak power2S-hes = 860.6 ± 70.37 W
P = 840.2 ± 118.93 W
McCormick, 2016 [52]Water polo players,
n = 9 (male)
Double-blind,
cross-over, RCT
90 mL Cherry juice (9.117 mg/mL of anthocyanins) a day for 7 daysWater polo intermittent swim testTotal distanceCJ = 605 ± 239 m
P = 558 ± 203 m
Nieman, 2010 [44]Adults, n = 26 (male)Double-blind,
cross-over, RCT
1000 mg Quercetin a
day for 2 weeks
12 min TTTotal distanceQ = 1013 ± 20.9 m
P = 990 ± 20.5 m
Overdevest, 2018 [53]Trained athletes,
n = 40 (male)
Double-blind, parallel,
RCT
500 mg Citrus Flavonoid
a day for 4 weeks
10 min TTAbsolut powerCF = 313 ± 43.6 W
P = 304.3 ± 51 W
Perkins, 2015 [54]Healthy adults, n = 13
(males)
Double-blind,
cross-over, RCT
300 mg New Zealand
Black Currant a day for
7 days
6 × 19 s of sprintsTotal distanceNZBC = 4282 ± 833 m
P = 3871 ± 622 m
Seeley, 2020 [55]Cyclists and triathletes,
n = 25 (male)
Double-blind,
cross-over, RCT
30 g Soy for once20-km TTTotal timeSoy = 35.31 ± 3.11 min
P = 35.53 ± 3.09 min
Sharp, 2012 [56]Healthy volunteers, n =
16 (male)
Double-blind,
cross-over, RCT
1000 mg Quercetin a
day for 8.5 day
200-kJ Cycle TTTotal timeQ = 18.3 ± 1.0 min
P = 18.5 ± 1.1 min
Van, 2021 [57]Moderately trained
volunteers, n = 93
(males and females)
Double-blind, parallel,
RCT
400 mg(a) or 500 mg(b)
Citrus Flavonoid extract
a day for 4 weeks
Wingate anaerobic testAverage powerCFE = 526 ± 150 W
P = 511 ± 140 W (a)
CFE = 575 ± 148 W
P = 511 ± 140 W (b)
Yarahmadi, 2014 [58]Athletes, n = 54
(22 female and 32 male)
Double-blind, parallel,
RCT
100 mg Anthocyanin a
day for 6 weeks
Bruce treadmill testVo2 maxAnt = 52.62 ± 5.04 L/min
P = 49.61 ± 5.33 L/min
RCT: randomized controlled trial; TT: time trial; P: placebo trial, L: group of low-dose; H: group of high-dose; Vo2 max: maximal oxygen uptake; ↑: improved athletic performance; →: unimproved athletic performance; (a), (b), (c) and (d) indicate certain paper uses more than one test or supplementation protocol.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wang, Y.; Tian, Z.; Li, Z.; Kim, J.C. Effects of Flavonoid Supplementation on Athletic Performance in Healthy Adults: A Systematic Review and Meta-Analysis. Nutrients 2023, 15, 4547. https://doi.org/10.3390/nu15214547

AMA Style

Wang Y, Tian Z, Li Z, Kim JC. Effects of Flavonoid Supplementation on Athletic Performance in Healthy Adults: A Systematic Review and Meta-Analysis. Nutrients. 2023; 15(21):4547. https://doi.org/10.3390/nu15214547

Chicago/Turabian Style

Wang, Ying, Zhuang Tian, Zhenyu Li, and Jae Cheol Kim. 2023. "Effects of Flavonoid Supplementation on Athletic Performance in Healthy Adults: A Systematic Review and Meta-Analysis" Nutrients 15, no. 21: 4547. https://doi.org/10.3390/nu15214547

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop